Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Historical Portfolio Holders from Q2 2018 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM STK CL A
Shares, excl. options Q2 2024
139M
Holdings value Q2 2024
$880M
Value change Q2 2024
+$192M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
179
Number of buys Q2 2024
14
Number of sells Q2 2024
-18
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 4.38M $36.5M +$2.57M $8.32 39
2024 Q2 139M $880M +$192M $6.35 180
2024 Q1 108M $655M -$6.55M $6.06 172
2023 Q4 109M $663M +$52.7M $6.07 151
2023 Q3 102M $430M +$19.7M $4.22 141
2023 Q2 97.4M $302M +$4.22M $3.10 122
2023 Q1 96.9M $135M -$8.21M $1.39 142
2022 Q4 102M $203M +$4.46M $1.99 154
2022 Q3 99.5M $201M -$1.68M $2.02 143
2022 Q2 99.4M $316M -$2.1M $3.18 140
2022 Q1 100M $417M -$2.78M $4.17 154
2021 Q4 101M $481M -$751K $4.79 148
2021 Q3 100M $535M +$2.52M $5.34 150
2021 Q2 99.9M $512M -$13.1M $5.12 153
2021 Q1 102M $684M +$24.8M $6.73 156
2020 Q4 99.5M $455M -$9.01M $4.57 128
2020 Q3 101M $394M -$1.37M $3.88 133
2020 Q2 102M $484M +$16.6M $4.76 131
2020 Q1 98.3M $342M -$17.3M $3.48 117
2019 Q4 101M $488M -$9.61M $4.82 116
2019 Q3 108M $314M -$46M $2.90 111
2019 Q2 105M $756M -$87.9M $7.17 117
2019 Q1 109M $1.54B -$98M $14.17 152
2018 Q4 116M $1.57B +$89.7M $13.53 157
2018 Q3 108M $2.41B +$283M $22.19 164
2018 Q2 97.5M $1.6B +$1.6B $16.41 162